National Comprehensive Cancer Network

About NCCN

NCCN Guidelines and Compendium Updated

Flash Update Sent June 20, 2012
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Lung Cancer Screening. These NCCN Guidelines® are currently available as Version 1.2013.

  • New footnote added describing the candidates for lung cancer screening: "Lung cancer screening is appropriate to consider for those high-risk patients who are potential candidates for definitive treatment."
  • For individuals who are candidates for screening, the interval has been revised: "Annual low-dose computed tomography (LDCT) for 2 years (category 1), and consider annual LDCT until patient no longer eligible for definitive treatment"
  • New footnote added to define criteria for suspicion of malignancy on PET-CT: "Criteria for suspicion of malignancy: hypermetabolism higher than the background of surrounding lung parenchyma, regardless of absolute standardized uptake value (SUV)."


For the complete updated version of these and all NCCN Guidelines, visit NCCN.org.